Findings that two mutated genes alter plant growth and development could result in improved plants and enhanced cancer treatments, according to Purdue University researchers.
This mutant plant is stouter and bushier than a normal plant because of an alteration in two genes related to human multidrug resistance genes. A Purdue University research team led by Angus Murphy is uncovering functions of these genes and the related proteins that could result in heartier plants and improved treatment for human cancers. (Purdue Agricultural Communication photo/Tom Campbell)
In a paper published in Thursdays (6/26) issue of Nature, the scientists report that these abnormal, or mutant plants are able to reorient themselves in response to light and gravity more rapidly than normal, or "wild type," plants. Apparently plants behave differently in accordance with how a growth hormone moves through them. Because the two genes affecting transport of the hormone are related to human genes that impact the effectiveness of chemotherapy drugs, controlling these genes may allow physicians to better determine the dosage of cancer drugs.
"We now know that if we can modify these genes, we can control the growth of the plant in very specific regions," said Angus Murphy, assistant professor of horticulture and senior author of the paper. "This means we might be able to change the shape of upper portions of a plant or develop a more robust root system."
Susan A. Steeves | Purdue News
Colorectal cancer: Increased life expectancy thanks to individualised therapies
20.02.2020 | Christian-Albrechts-Universität zu Kiel
Sweet beaks: What Galapagos finches and marine bacteria have in common
20.02.2020 | Max-Planck-Institut für Marine Mikrobiologie
The operational speed of semiconductors in various electronic and optoelectronic devices is limited to several gigahertz (a billion oscillations per second). This constrains the upper limit of the operational speed of computing. Now researchers from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg, Germany, and the Indian Institute of Technology in Bombay have explained how these processes can be sped up through the use of light waves and defected solid materials.
Light waves perform several hundred trillion oscillations per second. Hence, it is natural to envision employing light oscillations to drive the electronic...
Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.
Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...
Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices
The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...
Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.
Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.
After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.
"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.
12.02.2020 | Event News
16.01.2020 | Event News
15.01.2020 | Event News
21.02.2020 | Medical Engineering
21.02.2020 | Health and Medicine
21.02.2020 | Physics and Astronomy